Gram-negative shock: approaches to treatment.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000150:complications*; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005938:Glucocorticoids / Q000627:therapeutic use; D006090:Gram-Negative Bacteria; D006801:Humans; D007116:Immunization, Passive; D009270:Naloxone / Q000627:therapeutic use; D011817:Rabbits; D051381:Rats; D012772:Shock, Septic / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D005938:Glucocorticoids; D009270:Naloxone